24/01/2025
(ZANIS) The National Bio-safety Authority –NBA- has approved a Human Immunodeficiency Virus –HIV- vaccine to be undertaken by the Centre for Health Research in Zambia -CFHRZ.
The NBA Board approved the vaccine trial permit application at an extraordinary meeting in Lusaka.
In a statement availed to ZANIS, NBA Chief Executive Officer LACKSON TONGA said the permit granted to CFHRZ is for conducting research trials in Zambia and is valid for three years, adding that the experimental medicine vaccine trial will be administered to people living with HIV.
Credit ZNBC